Module

Neurologic Aspects of HIV Infection and Its Therapy

Source: HIV/AIDS Annual Update 2008

Neurologic Aspects of HIV Infection and Its Therapy

Faculty:

Justin C. McArthur, MBBS, MPH

CME CREDIT INFORMATION

Release Date: 06/05/08

Expiration Date: 06/04/09

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.9 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize diagnostic criteria and clinical features of HIV-associated neurocognitive disease (HAND) in the HAART era
Discuss changes in the incidence, prevalence, and progression of HAND before and after the introduction of HAART
Describe a system for ranking individual ARVs and ARV combinations for their ability to penetrate the central nervous system

Topics covered include:

Introduction
Definitions of HIV-Related Neurocognitive Impairment
Changes in Progression of HAND With HAART
Antiretroviral Penetration of the CNS
Summary: Implications for Clinical Practice

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.